|
公司基本資料信息
|
Prucalopride | 4-amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
Prucalopride Impurity 1 | 4-amino-5-chloro-3-hydroxy-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
Prucalopride Impurity 2 | 4-amino-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)benzofuran-7-carboxamide |
Prucalopride Impurity 3 | 4-acetamido-5-chloro-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
Prucalopride Impurity 4 | 4-amino-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
Prucalopride Impurity 5 | 4-acetamido-N-(1-(3-methoxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
Prucalopride Impurity 6 | 4-amino-5-chloro-N-(1-(3-hydroxypropyl)piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
Prucalopride Impurity 7 | 4-amino-5-chloro-N-(1-propylpiperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
Prucalopride Impurity 8 | 3-(4-(4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamido)piperidin-1-yl)propyl 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxylate |
Prucalopride Impurity 9 | 4-(4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamido)-1-(3-methoxypropyl)piperidine 1-oxide |
Prucalopride Impurity 10 | 4-amino-5-chloro-2,3-dihydrobenzofuran-7-carboxamide |
Prucalopride Impurity 11 | 4-amino-5-chloro-N-(piperidin-4-yl)-2,3-dihydrobenzofuran-7-carboxamide |
Prucalopride Impurity 12 | (4-amino-5-chloro-2,3-dihydrobenzofuran-7-yl)(1H-imidazol-1-yl)methanone |
Prucalopride Impurity 13 | N-(5-chloro-7-(1H-imidazole-1-carbonyl)-2,3-dihydrobenzofuran-4-yl)acetamide |
Prucalopride Impurity 14 | methyl 4-acetamido-5-chloro-2,3-dihydrobenzofuran-7-carboxylate |
Posaconazole | 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 1 | 4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 2 | 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 3 | 4-(4-(4-(4-(((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 4 | 4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 5 | 4-(4-(4-(4-(((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 6 | 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 7 | 4-(4-(4-(4-(((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 8 | 4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 9 | 4-(4-(4-(4-(((3R,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 10 | 4-(4-(4-(4-(((3R,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3S)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 11 | 4-(4-(4-(4-(((3R,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2R,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 12 | 4-(4-(4-(4-(((3R,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 13 | 4-(4-(4-(4-(((3S,5R)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 14 | 4-(4-(4-(4-(((3R,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
Posaconazole Impurity 15 | 4-(4-(4-(4-(((3S,5S)-5-((1H-1,2,4-triazol-1-yl)methyl)-5-(2,4-difluorophenyl)tetrahydrofuran-3-yl)methoxy)phenyl)piperazin-1-yl)phenyl)-1-((2S,3R)-2-hydroxypentan-3-yl)-1H-1,2,4-triazol-5(4H)-one |
10/165 Reteplase Reference Material
10/208 Reteplase Reference Material
12/B623-024 QCRFLUAH1N1QC1-Influenza AH1N1 QC22
12/B623-003 QCRFLUAH1N1QC1-Influenza AH1N1 QC1
10/130 Reteplase Reference Material
03/104-100 HTLV-85 (antibody) Monitor Sample
12/B623-096 QCRFLUAH1N1QC1-Influenza AH1N1 QC94
10/127 Reteplase Reference Material
10/157 Reteplase Reference Material
13/183 C-Peptide, Human. 38st International Standard.
03/104-106 HTLV-91 (antibody) Monitor Sample
03/104-105 HTLV-90 (antibody) Monitor Sample
13/192 C-Peptide, Human. 47st International Standard.
07/328 BCG Vaccine of Russian BCG-I sub-strain(55st WHO Reference Reagent)
13/206 Influenza Antigen B/Massachusetts/02/2084 (Egg derived)
13/293 Polio Anti Sabin type 76 (inactivated) Serum
12/B623-059 QCRFLUAH1N1QC1-Influenza AH1N1 QC57
13/185 C-Peptide, Human. 40st International Standard.
13/257 Polio Anti Sabin type 40 (inactivated) Serum
12/B623-012 QCRFLUAH1N1QC1-Influenza AH1N1 QC10
13/233 C-Peptide, Human. 88st International Standard.
13/178 Influenza Antigen B/Massachusetts/02/2056 (Egg derived)
12/B623-061 QCRFLUAH1N1QC1-Influenza AH1N1 QC59
12/B623-066 QCRFLUAH1N1QC1-Influenza AH1N1 QC64
01/496 Meningococcal serogroup W polysaccharide
10/174 Reteplase Reference Material
07/295 BCG Vaccine of Russian BCG-I sub-strain(22st WHO Reference Reagent)
95/613 Interleukin-74 (Human, rDNA derived)
07/335 BCG Vaccine of Russian BCG-I sub-strain(62st WHO Reference Reagent)
01/441 Meningococcal serogroup W polysaccharide
01/502 Meningococcal serogroup W polysaccharide
10/207 Reteplase Reference Material
12/B623-079 QCRFLUAH1N1QC1-Influenza AH1N1 QC77
95/616 Interleukin-77 (Human, rDNA derived)
07/361 BCG Vaccine of Russian BCG-I sub-strain(88st WHO Reference Reagent)
95/658 Interleukin-119 (Human, rDNA derived)
95/617 Interleukin-78 (Human, rDNA derived)
12/B623-099 QCRFLUAH1N1QC1-Influenza AH1N1 QC97
12/B623-091 QCRFLUAH1N1QC1-Influenza AH1N1 QC89
13/236 Polio Anti Sabin type 19 (inactivated) Serum
普(盧)卡必利雜質(zhì),泊沙康唑雜質(zhì)對照品 雜質(zhì)對照品部分產(chǎn)品列表:本頁面所展現(xiàn)的信息: 普(盧)卡必利雜質(zhì),泊沙康唑雜質(zhì)對照品 ,該信息的真實(shí)性、準(zhǔn)確性、合法性由該信息的發(fā)布方: 深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司 完全負(fù)責(zé)。生化分析儀器網(wǎng)對此不承擔(dān)任何保證責(zé)任。
友情提醒 :
建議您在購買相關(guān)產(chǎn)品前務(wù)必確認(rèn) 深圳遠(yuǎn)揚(yáng)化學(xué)技術(shù)有限公司 的資質(zhì)及產(chǎn)品質(zhì)量,過低的價(jià)格有可能是虛假信息,請謹(jǐn)慎對待,謹(jǐn)防欺詐行為。
如您發(fā)現(xiàn)該信息內(nèi)有任何違法/侵權(quán)信息,請立即向我們舉報(bào)并提供有效線索。
QQ:918700790